Recent insights into non-nuclear actions of estrogen receptor alpha, Steroids, vol.81, pp.64-73, 2014. ,
Estrogen dependent signaling in reproductive tissues-A role for estrogen receptors and estrogen related receptors, Mol Cell Endocrinol, vol.348, pp.361-372, 2012. ,
Function of G-Protein-Coupled Estrogen Receptor-1. In Reproductive System Tumors, J Immunol Res, p.7128702, 2016. ,
Estrogen receptor-alpha variant, ER-alpha 36, is involved in tamoxifen resistance and estrogen hypersensitivity, Endocrinology, vol.154, pp.2013-1116, 1990. ,
Estrogen activation of the mitogen-activated protein kinase is mediated by ER-alpha36 in ER-positive breast cancer cells, J Steroid Biochem Mol Biol, vol.143, pp.434-443, 2014. ,
Disruption of the ER-alpha36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells, PLoS ONE, vol.9, issue.9, p.107369, 2014. ,
Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER dependent ERalpha36 induction, Mol Cell Endocrinol, vol.350, pp.61-71, 2012. ,
An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism, PLoS ONE, vol.8, issue.4, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00840880
, ER?36-dependent disruption of mammary epithelium, PLOS ONE, 2017.
Environmental causes of cancer: endocrine disruptors as carcinogens, Nat Rev Endocrinol, vol.6, issue.7, pp.363-70, 2010. ,
Is breast cancer initiated in utero?, Epidemiology, vol.1, issue.2, pp.95-101, 1990. ,
Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal BPA exposure, Reprod Toxicol, vol.23, issue.3, pp.383-90, 2007. ,
Endocrine-disrupting chemicals: review of toxicological mechanisms using molecular pathway analysis, J Cancer Prev, vol.20, issue.1, pp.12-24, 2015. ,
Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption, J Steroid Biochem Mol Biol, vol.102, issue.1-5, pp.175-184, 2006. ,
Integrated Risk Assessment: Nonylphenol Case Study, Geneva: International Programme on Chemical Safety, 2004. ,
he efects of 4-nonylphenol in rats: a multigeneration reproduction study, Toxicol Sci, vol.52, issue.1, pp.80-91, 1999. ,
hreegeneration evaluation of dietary para-nonylphenol in CD-(Sprague-Dawley) rats, Toxicol Sci, vol.92, issue.1, pp.295-310, 2006. ,
he contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol-treated MMTVneu mice and its potential efects on breast cancer incidence and latency, J Appl Toxicol, vol.25, issue.5, pp.339-53, 2005. ,
Gestational exposure to nonylphenol causes precocious mammary gland development in female rat ofspring, J Reprod Dev, vol.53, issue.2, pp.333-377, 2007. ,
p-Nonyl-phenol: an estrogenic xenobiotic released from "modiied" polystyrene, Environ Health Perspect, vol.92, pp.167-73, 1991. ,
Endocrine disrupting nonyland octylphenol in infant food in Germany: considerable daily intake of nonylphenol for babies, Chemosphere, vol.82, issue.11, pp.1533-1573, 2011. ,
An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism, PLoS One, vol.8, issue.4, p.61758, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00840880
Transgenerational actions of environmental compounds on reproductive disease and identiication of epigenetic biomarkers of ancestral exposures, PLoS One, vol.7, issue.2, p.31901, 2012. ,
Identiication, cloning, and expression of human ER?36, a novel variant of human ER?66, Biochem Biophys Res Commun, vol.336, issue.4, pp.1023-1030, 2005. ,
Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression, PLoS One, vol.12, issue.3, p.173931, 2017. ,
High bioavailability of bisphenol A from sublingual exposure, Environ Health Perspect, vol.121, pp.951-957, 2013. ,
Efects of p-nonylphenol (NP) and diethylstilboestrol (DES) on the Alderley Park (Alpk) rat: comparison of mammary gland and uterus sensitivity following oral gavage or implanted mini-pumps, J Appl Toxicol, vol.19, issue.5, pp.367-78, 1999. ,
Comparative activities of p-nonylphenol and diethylstilbestrol in noble rat mammary gland and uterotrophic assays, Regul Toxicol Pharmacol, vol.29, issue.2, pp.184-95, 1999. ,
, Frontiers in Endocrinology | www.frontiersin.org October, vol.8, p.272, 2017.
Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland, Endocrinology, vol.148, issue.1, pp.116-143, 2007. ,
Data-driven modeling and characterization of anti-angiogenic molecule efects on tumoral vascular density, Biomed Signal Process Control, vol.20, pp.52-60, 2015. ,
Multiscale vessel enhancement iltering, Proceedings from MICCAI'98, vol.1496, pp.130-137, 1998. ,
Morphology of the fetal rat testis preserved in diferent ixatives, Toxicol Pathol, vol.33, issue.2, pp.300-304, 2005. ,
PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements, Nucleic Acids Res, pp.331-339, 2016. ,
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, vol.34, issue.3, pp.267-73, 2003. ,
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression proiles, Proc Natl Acad Sci U S A, vol.102, issue.43, pp.15545-50, 2005. ,
Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10, Cancer Res, vol.50, issue.18, pp.6075-86, 1990. ,
Standard deviations and standard errors, BMJ, vol.331, p.903, 2005. ,
Detection of genomic instability in lung cancer tissues by random ampliied polymorphic DNA analysis, Carcinogenesis, vol.19, issue.1, pp.233-238, 1998. ,
Assessment of genomic instability in breast cancer and uveal melanoma by random ampliied polymorphic DNA analysis, Int J Cancer, vol.99, issue.2, pp.193-200, 2002. ,
Exposure of environmental estrogenic compound nonlyphenol to noble rats alters cell-cycle kinetics in the mammary gland, Endocrine, vol.4, issue.2, pp.115-137, 1996. ,
Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice, Environ Health Perspect, vol.119, pp.1604-1613, 2011. ,
Altered carcinogenesis and proteome in mammary glands of rats ater prepubertal exposures to the hormonally active chemicals bisphenol A and genistein, J Nutr, vol.142, issue.7, pp.1382-1390, 2012. ,
Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ER alpha expression and reduce rat mammary tumorigenesis, Cancer Epidemiol, vol.33, issue.1, pp.51-56, 2009. ,
Circulating serum xenoestrogens and mammographic breast density, Breast Cancer Res, vol.15, issue.3, p.45, 2013. ,
Estrogens in the wrong place at the wrong time: fetal BPA exposure and mammary cancer, Reprod Toxicol, vol.54, pp.58-65, 2015. ,
4-Nonylphenol induces disruption of spermatogenesis associated with oxidative stress-related apoptosis by targeting p53-Bcl-2/Bax-Fas/FasL signaling, Environ Toxicol, vol.32, issue.3, pp.739-53, 2016. ,
Perinatal exposure to the xenoestrogen bisphenol-A induces mammary intraductal hyperplasias in adult CD-1 mice, Reprod Toxicol, vol.26, issue.3-4, pp.210-219, 2008. ,
Male-mediated F1 efects in mice exposed to nonylphenol or to a combination of X-rays and nonylphenol, Drug Chem Toxicol, vol.35, issue.1, pp.36-42, 2012. ,
Genotoxicity of 4-nonylphenol and nonylphenol ethoxylate mixtures by the use of Saccharomyces cerevisiae D7 mutation assay and use of this text to evaluate the eiciency of biodegradation treatments, Ecotoxicol Environ Saf, vol.74, issue.3, pp.253-261, 2011. ,
Nonylphenol efects on human prostate non tumorigenic cells, Toxicology, pp.357-358, 2016. ,
Inhibition of staurosporine-induced neuronal cell death by BPA and nonylphenol in primary cultured rat hippocampal and cortical neurons, Neurosci Lett, vol.353, issue.2, pp.99-102, 2003. ,
Nonylphenol diethoxylate inhibits apoptosis induced in PC12 cells, Environ Toxicol, issue.11, pp.1389-98, 2016. ,
Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland, PLoS One, vol.8, issue.5, p.6390202, 2013. ,
An evaluation on combination efects of phenolic endocrine disruptors by ER binding assay, Toxicol In Vitro, vol.26, issue.6, pp.769-74, 2012. ,
ERalpha36: a new player in human breast cancer, Mol Cell Endocrinol, vol.418, issue.3, pp.193-206, 2015. ,
he molecular mechanisms underlying the ER?-36-mediated signaling in breast cancer, Oncogene, vol.36, issue.18, pp.2503-2517, 2017. ,
From ER?66 to ER?36: a generic method for validating a prognosis marker of breast tumor progression, BMC Syst Biol, vol.9, p.28, 2015. ,
Resistance to endocrine therapy in breast cancer: Molecular mechanisms and future goals, Breast Cancer Res. Treat, vol.173, pp.489-497, 2019. ,
, Int. J. Mol. Sci, vol.20, p.2637, 2019.
Tamoxifen enhances stemness and promotes metastasis of ER?36+ breast cancer by upregulating ALDH1A1 in cancer cells, Cell Res, vol.28, pp.336-358, 2018. ,
A variant of estrogen receptor-?, hER-?36: Transduction of estrogen-and antiestrogen-dependent membrane-initiated mitogenic signaling, Proc. Natl. Acad. Sci, vol.103, pp.9063-9068, 2006. ,
Estrogen receptor-? variant, ER-?36, is involved in tamoxifen resistance and estrogen hypersensitivity, Endocrinology, vol.154, 1990. ,
Estrogen receptor-?36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells, Mol. Oncol, vol.7, pp.611-624, 2013. ,
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66, Biochem. Biophys. Res. Commun, vol.336, pp.1023-1027, 2005. ,
Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism, Biochim. Biophys. Acta, vol.1843, pp.2796-2806, 2014. ,
The molecular mechanisms underlying the ER?-36-mediated signaling in breast cancer, vol.36, pp.2503-2514, 2017. ,
Role of ER?36 in membrane-associated signaling by estrogen, Steroids, vol.81, pp.74-80, 2014. ,
Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression, PLoS ONE, vol.12, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01492524
Estrogen receptor alpha-36 (ER-?36): A new player in human breast cancer, Mol. Cell. Endocrinol, vol.418, pp.193-206, 2015. ,
ER?36-Another piece of the estrogen puzzle, Eur. J. Cell Biol, vol.94, pp.611-625, 2015. ,
From ER?66 to ER?36: A generic method for validating a prognosis marker of breast tumor progression, BMC Syst. Biol, vol.9, p.28, 2015. ,
Estrogen receptor-alpha (ER-?) suppresses expression of its variant ER-?36, FEBS Lett, vol.583, pp.1368-1374, 2009. ,
Roles of the ER-?36-EGFR/HER2 positive regulatory loops in tamoxifen resistance, Steroids, vol.111, pp.95-99, 2016. ,
Low-Dose Alkylphenol Exposure Promotes Mammary Epithelium Alterations and Transgenerational Developmental Defects, But Does Not Enhance Tumorigenic Behavior of Breast Cancer Cells ,
MicroRNA epigenetic signatures in human disease, Arch. Toxicol, vol.90, pp.2405-2419, 2016. ,
Jin, X. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer, Oncol. Rep, vol.36, pp.65-71, 2016. ,
Long noncoding RNA CRNDE activates Wnt/?-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer, Am. J. Transl. Res, vol.9, pp.1977-1989, 2017. ,
MicroRNA-136 functions as a tumor suppressor in osteosarcoma via regulating metadherin, Cancer Biomark. Sect. Dis. Markers, vol.22, pp.79-87, 2018. ,
miR-136-5p Regulates the Inflammatory Response by Targeting the IKK?/NF-?B/A20 Pathway After Spinal Cord Injury, Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol, vol.50, pp.512-524, 2018. ,
, Int. J. Mol. Sci, vol.20, p.2637, 2019.
Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis, Pathol. Res. Pract, vol.214, pp.644-654, 2018. ,
Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma, Oncol. Lett, vol.15, pp.5995-6002, 2018. ,
Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis, Pathol. Res. Pract, vol.214, pp.750-766, 2018. ,
Annotating high confidence microRNAs using deep sequencing data, Nucleic Acids Res, vol.42, pp.68-73, 2014. ,
Integrating microRNA annotation and deep-sequencing data, Nucleic Acids Res, vol.39, pp.152-157, 2011. ,
miRBase: microRNA sequences, targets and gene nomenclature, Nucleic Acids Res, vol.34, pp.140-144, 2006. ,
Tools for microRNA genomics, Nucleic Acids Res, vol.36, pp.154-158, 2008. ,
miRmine: A database of human miRNA expression profiles, Bioinform. Oxf. Engl, vol.33, pp.1554-1560, 2017. ,
Regulatory mechanisms of microRNA expression, J. Transl. Med, vol.14, p.143, 2016. ,
Imprinting disorders: A group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci, Clin. Epigenetics, vol.7, issue.123, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01231437
14q32-encoded microRNAs mediate an oligometastatic phenotype, Oncotarget, vol.6, pp.3540-3552, 2015. ,
Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes, Toxicology, vol.410, pp.231-246, 2018. ,
An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism, PLoS ONE, vol.8, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00840880
A New Role for ER?: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes, Mol. Cancer Res, vol.15, pp.152-164, 2017. ,
Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-?36 (ER?36), J. Biol. Chem, vol.287, pp.7169-7181, 2012. ,
Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer, J. Clin. Oncol, vol.27, pp.3423-3429, 2009. ,
DNA methylation at enhancers identifies distinct breast cancer lineages, Nat. Commun, vol.8, p.1379, 2017. ,
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer, Oncogene, vol.35, pp.2746-2755, 2016. ,
Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis, Breast Cancer Res, vol.15, 2013. ,
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine, J. Clin. Invest, vol.128, pp.2376-2388, 2018. ,
, Int. J. Mol. Sci, vol.20, p.2637, 2019.
Reversal of ER-? silencing by chromatin modifying agents overrides acquired tamoxifen resistance, Cancer Lett, vol.337, pp.167-176, 2013. ,
MicroRNA-136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen-activated protein kinase kinase 4, Mol. Med. Rep, vol.17, pp.4803-4810, 2018. ,
The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2, Oncotarget, vol.8, pp.88163-88178, 2017. ,
Ultraviolet radiation-induced differential microRNA expression in the skin of hairless SKH1 mice, a widely used mouse model for dermatology research, Oncotarget, vol.7, pp.84924-84937, 2016. ,
Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ER?36 induction, Mol. Cell. Endocrinol, vol.350, pp.61-71, 2012. ,
MicroRNA gene expression deregulation in human breast cancer, Cancer Res, vol.65, pp.7065-7070, 2005. ,
Zawlik, I. Dysregulation of microRNAs in triple-negative breast cancer, Ginekol. Pol, vol.88, pp.530-536, 2017. ,
Aberrant miRNAs expressed in HER-2 negative breast cancers patient, J. Exp. Clin. Cancer Res, vol.37, 2018. ,
Identifying a miRNA signature for predicting the stage of breast cancer, Sci. Rep, vol.8, 2018. ,
A three-microRNA signature predicts clinical outcome in breast cancer patients, Eur. Rev. Med. Pharmacol. Sci, vol.22, pp.6386-6395, 2018. ,
The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: Hierarchical interaction and distinct functional properties as imprinting control centers ,
Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma, Cell. Physiol. Biochem, vol.50, pp.2229-2248, 2018. ,
Hsa_circ_0008309 May Be a Potential Biomarker for Oral Squamous Cell Carcinoma, Dis. Markers, vol.7496890, 2018. ,
Sulfasalazine alters microglia phenotype by competing endogenous RNA effect of miR-136-5p and long non-coding RNA HOTAIR in cuprizone-induced demyelination, Biochem. Pharmacol, vol.155, pp.110-123, 2018. ,
Colorectal neoplasia differentially expressed: A long noncoding RNA with an imperative role in cancer, OncoTargets Ther, vol.11, pp.3755-3763, 2018. ,
The prognostic role of long noncoding RNA CRNDE in cancer patients: A systematic review and meta-analysis, Neoplasma, vol.66, pp.73-82, 2019. ,
A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context, Mol. Cell. Biol, vol.31, pp.2513-2527, 2011. ,
TNM classification of malignant tumors ,
CrossRef] REFERENCES and performed the functional analysis that follows the covariates selection with armada. Stefano Cairo and Olivier Déas, XenTech, Genopole -Campus, vol.331, p.903, 2005. ,
Identité des Tumeurs program provided the access to transcriptomic raw data and biological samples (ERa66+, PR+, PR-datasets). The statistical methodology has been developed by Anne Gégout-Petit and Aurélie Muller-Gueudin, and thanks to Yaojie Shi and Hafid Chakir during their Master internships. References Antanavi?i?t?, Ieva, Mikalayeva, Valeryia, Ceslevi?ien?, Ieva, Mila?i?t?, Gintar?, Skeberdis, Vytenis Arvydas and Bordel, Scientific reports, vol.7, issue.1, p.7820, 2017. ,
, , 2004.
, Determination of the differentially expressed genes in microarray experiments using local fdr, BMC bioinformatics, vol.5, issue.1, p.1
Comparaisons multiples pour les microarrays, Journal de la Société Française de Statistique, vol.146, issue.1-2, pp.45-62, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01219538
Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society, 1995. ,
, Series B (Methodological, pp.289-300
The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics, pp.1165-1188, 2001. ,
Teoria statistica delle classi e calcolo delle probabilita, 1936. ,
, , 2011.
, Factor analysis for multiple testing (famt): an R package for large-scale significance testing under dependence, Journal of Statistical Software, vol.40, issue.14, p.19
From ER?66 to ER?36: a generic method for validating a prognosis marker of breast tumor progression, BMC systems biology, vol.9, issue.1, p.28, 2015. ,
Clustofvar: an R package for the clustering of variables, Journal of Statistical Software, vol.50, pp.91-116, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00646805
Multiple testing. part I. single-step procedures for control of general type I error rates, Statistical Applications in Genetics and Molecular Biology, vol.3, issue.1, pp.1-69, 2004. ,
Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments, Statistica sinica, pp.111-139, 2002. ,
Local false discovery rates. Division of Biostatistics, 2005. ,
Impact of dependence in large-scale multiple testing, 2012. ,
URL : https://hal.archives-ouvertes.fr/tel-00539741
Estimation of the proportion of true null hy-REFERENCES potheses in high-dimensional data under dependence, Computational Statistics & Data Analysis, vol.55, issue.9, pp.2665-2676, 2011. ,
A factor model approach to multiple testing under dependence, Journal of the American Statistical Association, vol.104, issue.488, pp.1406-1415, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00458049
Variable selection using random forests, Pattern Recognition Letters, vol.31, issue.14, pp.2225-2236, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00755489
Novel multivariate methods for integration of genomics and proteomics data: applications in a kidney transplant rejection study, Omics: a journal of integrative biology, vol.18, issue.11, pp.682-695, 2014. ,
Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems, BMC bioinformatics, vol.12, issue.1, p.1, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00959981
Micro-rnas and breast cancer, Molecular oncology, vol.4, issue.3, pp.230-241, 2010. ,
The group lasso for logistic regression, Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol.70, issue.1, pp.53-71, 2008. ,
High-dimensional graphs and variable selection with the lasso, The Annals of Statistics, pp.1436-1462, 2006. ,
, , 2019.
Microarray data analysis : feature selection, clustering and prediction, pp.1-40, 2016. ,
A direct approach to false discovery rates, Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol.64, issue.3, pp.479-498, 2002. ,
The positive false discovery rate: a bayesian interpretation and the q-value, The Annals of Statistics, pp.2013-2035, 2003. ,
Statistical significance for genomewide studies, Proceedings of the National Academy of Sciences, vol.100, issue.16, pp.9440-9445, 2003. ,
Rankgene: identification of diagnostic genes based on expression data, Bioinformatics, vol.19, issue.12, pp.1578-1579, 2003. ,
PLS path modeling, Computational Statistics & Data Analysis, vol.48, issue.1, pp.159-205, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00869374
Regression shrinkage and selection via the lasso, Journal of the Royal Statistical Society. Series B (Methodological, pp.267-288, 1996. ,
Identification, cloning, and expression of human estrogen receptor-?36, a novel variant of human estrogen receptor-?66, the Oncogenetics laboratory, INSERM U735, Institut Curie-Hôpital-Centre René Huguenin, vol.336, pp.1023-1027, 2005. ,
, The measurement of ER?36 expression in each tumor (Step 1: clinical data completion) has been done as described in Thiebaut and others, 2017.
, Assays were performed at least in triplicate, and the mean values were used to calculate expression levels
A refined molecular taxonomy of breast cancer, Oncogene, vol.31, issue.9, p.1196, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00611752
Molecular profiling of patient-derived breast cancer xenografts, R11. traductionnelles des histones, comme les HDACs ou les HMTs, vol.14, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00675301
Soto ont mis en évidence que l'exposition foetale ou néonatale au BPA perturbe la signalisation oestrogénique et conduit à l'apparition d'altérations structurales de la glande mammaire, En parallèle, étant donné que différentes études menées par l'équipe d'Ana M, 2005. ,
Au total, nous avons mis en évidence 12 micro-ARNs susceptibles d'interagir avec la région 3'UTR de l'ARNm de ce variant et nous avons validé l'implication d'hsa-miR-136-5p dans la régulation négative de l'expression d'ER?36. A l'heure actuelle, les études disponibles dans la littérature indiquent que le niveau d'expression de hsa-miR-136-5p ne constitue pas un marqueur pronostic suffisant pour prédire le devenir des patientes, Pour finir, nous avons exploré au cours de ces travaux les mécanismes de régulation posttranscriptionnelle de l'expression d, 2017. ,
Ainsi, l'analyse de ces ARNs qui se comportent comme, 2018. ,
Par exemple, le répertoire en micro-ARNs dans des testicules de rats adultes est fortement perturbé après une exposition chronique (du jour de la conception à l'âge adulte) à de faibles doses d'un mélange d'alkylphénols et de phtalates, 2016. ,
ont montré que le BPA module l'expression de plusieurs micro-ARNs, et notamment du micro-ARN oncogénique hsa-miR-21, 2012. ,
S-palmitoylation modulates human estrogen receptor-alpha functions, Biochem. Biophys. Res. Commun, vol.316, pp.878-883, 2004. ,
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines, Mol. Endocrinol. Baltim. Md, vol.21, pp.1132-1147, 2007. ,
Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover, BMC Cancer, vol.14, p.278, 2014. ,
An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism, PLoS ONE, vol.8, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00840880
Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test Methods, Basic Clin. Pharmacol. Toxicol, vol.122, pp.38-45, 2018. ,
Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.3983-3988, 2003. ,
Regulation of estrogen receptor ?1 expression in breast cancer by epigenetic modification of the 5? regulatory region, Int. J. Oncol, vol.43, 2013. ,
Detection of novel germline mutations for breast cancer in non-BRCA1/2 families, FEBS J, vol.282, pp.3424-3437, 2015. ,
The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer, Breast Cancer Res. Treat, vol.118, pp.323-331, 2009. ,
Transcriptional hallmarks of cancer cell lines reveal an emerging role of branched chain amino acid catabolism, 2017. ,
Nuclear hormone receptors and gene expression, Physiol. Rev, vol.81, pp.1269-1304, 2001. ,
A New Role for ER?: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes, Mol. Cancer Res, vol.15, pp.152-164, 2017. ,
STAT3 upregulates the protein expression and transcriptional activity of ?-catenin in breast cancer, Int. J. Clin. Exp. Pathol, vol.3, pp.654-664, 2010. ,
Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions, J. Am. Soc. Nephrol, vol.18, pp.2004-2013, 2007. ,
TGF?/TNF?-Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype, Cancer Res, vol.71, pp.4707-4719, 2011. ,
Gata-3 is an essential regulator of mammarygland morphogenesis and luminal-cell differentiation, Nat. Cell Biol, vol.9, pp.201-209, 2007. ,
High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring, Nat. Commun, vol.3, p.1053, 2012. ,
Characterization of the proximal estrogen-responsive element of human cathepsin D gene, Mol. Endocrinol. Baltim. Md, vol.8, pp.693-703, 1994. ,
Perinatal Exposure to Bisphenol A Increases Adult Mammary Gland Progesterone Response and Cell Number, Mol. Endocrinol, vol.25, pp.1915-1923, 2011. ,
Functional Interactions between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein, J. Biol. Chem, vol.278, pp.22119-22127, 2003. ,
Targeted and genome-scale methylomics reveals gene body signatures in human cell lines, Nat. Biotechnol, vol.27, pp.361-368, 2009. ,
Constitutive activation of STAT3 in breast cancer cells: A review, Int. J. Cancer, vol.138, pp.2570-2578, 2016. ,
Les microARN circulants, une nouvelle classe de biomarqueurs pour la médecine. médecine/sciences, vol.30, pp.289-296, 2014. ,
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis, Cell. Mol. Life Sci. CMLS, vol.70, pp.795-814, 2013. ,
Minireview: Tipping the Balance: Ligand-Independent Activation of Steroid Receptors, Mol. Endocrinol, vol.29, pp.349-363, 2015. ,
Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells, Proc. Natl. Acad. Sci. U. S. A, vol.97, pp.8542-8547, 2000. ,
Induction of mammary gland development in estrogen receptor-alpha knockout mice, Endocrinology, vol.141, pp.2982-2994, 2000. ,
Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications, Trends Pharmacol. Sci, vol.21, pp.381-388, 2000. ,
PELP1 -A Novel Estrogen Receptor-Interacting Protein, Mol. Cell. Endocrinol, vol.290, pp.2-7, 2008. ,
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J. Clin, vol.68, pp.394-424, 2018. ,
Hormone action in the mammary gland, Cold Spring Harb. Perspect. Biol, vol.2, p.3178, 2010. ,
Epigenetics and autoimmune diseases: the X chromosomenucleolus nexus, Front. Genet, vol.6, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01132409
Aromatase, breast cancer and obesity: a complex interaction, Trends Endocrinol. Metab. TEM, vol.23, pp.83-89, 2012. ,
, , 2017.
Tamoxifen and ER?36: Fertilizing the seeds of breast cancer metastasis, Cell Res, vol.28, pp.391-392, 2018. ,
Genome-wide activity of unliganded estrogen receptor-? in breast cancer cells, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.4892-4897, 2014. ,
, , 2001.
, Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor ?: A NEW MODEL FOR ANTI-ESTROGEN RESISTANCE, J. Biol. Chem, vol.276, pp.9817-9824
Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer, Genomics, vol.45, pp.607-617, 1997. ,
, , 2011.
, Estrogen signaling in testicular cells, Life Sci, vol.89, pp.584-587
Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer, Eur. J. Endocrinol, vol.175, pp.41-49, 2016. ,
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1, Cell, vol.122, pp.33-43, 2005. ,
Deciphering the divergent roles of progestogens in breast cancer, Nat. Rev. Cancer, vol.17, pp.54-64, 2017. ,
The estrogen receptor-?-induced microRNA signature regulates itself and its transcriptional response, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.15732-15737, 2009. ,
Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition, Nucleic Acids Res, vol.32, pp.1957-1966, 2004. ,
Rôle de RIP140 dans la signalisation hormonale. médecine/sciences 21, pp.273-278, 2005. ,
Rapid Estradiol/ER? Signaling Enhances Aromatase Enzymatic Activity in Breast Cancer Cells, Mol. Endocrinol, vol.23, pp.1634-1645, 2009. ,
Biology of FOXM1 and its emerging role in cancer therapy, J. Proteins Proteomics, vol.5, 2014. ,
From ER?66 to ER?36: a generic method for validating a prognosis marker of breast tumor progression, BMC Syst. Biol, vol.9, p.28, 2015. ,
ERbeta has nongenomic action in caveolae, Mol. Endocrinol. Baltim. Md, vol.16, pp.938-946, 2002. ,
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial, JAMA Oncol, vol.2, pp.1310-1315, 2016. ,
The dynamic expression pattern of B lymphocyte induced maturation protein-1 (Blimp-1) during mouse embryonic development, Mech. Dev, vol.117, pp.305-309, 2002. ,
Combinations of parabens at concentrations measured in human breast tissue can increase proliferation of MCF-7 human breast cancer cells, J. Appl. Toxicol, vol.33, pp.390-398, 2013. ,
Epigenetic drivers of tumourigenesis and cancer metastasis, Semin. Cancer Biol, vol.51, pp.149-159, 2018. ,
, , 2012.
, Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-?36 (ER?36), J. Biol. Chem, vol.287, pp.7169-7181
Estrogen receptoralpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism, Biochim. Biophys. Acta, vol.1843, pp.2796-2806, 2014. ,
Role of ER?36 in membrane-associated signaling by estrogen, Steroids, vol.81, pp.74-80, 2014. ,
miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer, Cancer Lett, vol.356, pp.410-417, 2015. ,
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression, Theranostics, vol.8, pp.4003-4015, 2018. ,
Tumor suppressor microRNA 136 5p regulates the cellular function of renal cell carcinoma, Oncol. Lett, vol.15, pp.5995-6002, 2018. ,
Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues, J. Steroid Biochem. Mol. Biol, vol.72, pp.23-27, 2000. ,
Study of mammary stem and progenitor cells and of their contribution in tumorigenesis : role of transcriptional factors Myc and p53, 2012. ,
URL : https://hal.archives-ouvertes.fr/tel-00924981
The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation-and estrogen-dependent gene expression in antiestrogen-resistant breast cancer, Cancer Res, vol.65, pp.18-25, 2005. ,
Constitutive Activation of STAT3 Signaling Regulates hTERT and Promotes Stem Cell-Like Traits in Human Breast Cancer Cells, PLOS ONE, vol.8, p.83971, 2013. ,
,
, Perimembrane localization of the estrogen receptor alpha protein in neuronal processes of cultured hippocampal neurons, Neuroendocrinology, vol.71, pp.34-42
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet Lond. Engl, vol.366, pp.2087-2106, 2005. ,
Estetrol review: profile and potential clinical applications, Climacteric J. Int. Menopause Soc, vol.11, issue.1, pp.47-58, 2008. ,
Formation du complexe d'initiation de la transcription : des facteurs généraux aux complexes qui déstabilisent la chromatine. médecine/sciences 16, p.593, 2000. ,
Activation of nuclear factor-kappa B in mammary epithelium promotes milk loss during mammary development and infection, J. Cell. Physiol, vol.222, pp.73-81, 2010. ,
Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression, Mol. Cell, vol.21, pp.555-564, 2006. ,
Cooperative Dynamics of AR and ER Activity in Breast Cancer, Mol. Cancer Res. MCR, vol.14, pp.1054-1067, 2016. ,
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, Lancet Lond. Engl, vol.381, pp.805-816, 2013. ,
Transcriptional regulation of estrogen receptor in breast carcinomas, Mol. Cell. Biol, vol.15, pp.2191-2196, 1995. ,
Global Gene Expression Analysis of Estrogen Receptor Transcription Factor Cross Talk in Breast Cancer: Identification of Estrogen-Induced/Activator Protein-1-Dependent Genes, Mol. Endocrinol, vol.19, pp.362-378, 2005. ,
Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth, Mol. Cell. Endocrinol, vol.277, pp.13-25, 2007. ,
A variant of estrogen receptor-?, ER-?36 is expressed in human gastric cancer and is highly correlated with lymph node metastasis, Oncol. Rep, vol.24, pp.171-176, 2010. ,
Regulation of mammalian DNA methyltransferases: a route to new mechanisms, EMBO Rep, vol.12, pp.647-656, 2011. ,
An Emerging Role of micro-RNA in the Effect of the Endocrine Disruptors, Front. Neurosci, vol.10, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01471933
Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ER?) and Biochemical Characterization of the ER?-Hsp70 Interaction, PloS One, vol.11, p.160312, 2016. ,
Prenatal Exposure to BPA Alters the Epigenome of the Rat Mammary Gland and Increases the Propensity to Neoplastic Development, PLoS ONE, vol.9, 2014. ,
Long Noncoding RNA HOTAIR Modulates MiR-206-mediated Bcl-w Signaling to Facilitate Cell Proliferation in, Breast Cancer. Sci. Rep, vol.7, p.17261, 2017. ,
Breast cancer stem cells: Features, key drivers and treatment options, Semin. Cancer Biol, vol.53, pp.59-74, 2018. ,
Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.9, pp.594-600, 2003. ,
Sequence requirements for estrogen receptor binding to estrogen response elements, J. Biol. Chem, vol.273, pp.29321-29330, 1998. ,
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM), Eur. J. Cancer Oxf. Engl, vol.75, pp.284-298, 1990. ,
The AP-2 family of transcription factors, Genome Biol, vol.6, p.246, 2005. ,
Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer, Cancer Res, vol.67, pp.6477-6483, 2007. ,
DNA methylation and differentiation: silencing, upregulation and modulation of gene expression, Epigenomics, vol.5, pp.553-568, 2013. ,
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways, Cancer Treat. Rev, vol.38, pp.698-707, 2012. ,
Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data, CMAJ Open, vol.5, pp.734-739, 2017. ,
Structural and Functional Diversity of Estrogen Receptor Ligands, Curr. Top. Med. Chem, vol.15, pp.1372-1384, 2015. ,
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis, Genes Dis, vol.5, pp.77-106, 2018. ,
Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology, Endocrinology, vol.153, pp.2953-2962, 2012. ,
Identification of a new isoform of the human estrogen receptor-alpha (hER-?) that is encoded by distinct transcripts and that is able to repress hER-? activation function 1, EMBO J, vol.19, pp.4688-4700, 2000. ,
ER? in Breast Cancer -Onlooker, Passive Player, or Active Protector?, Steroids, vol.73, pp.1039-1051, 2008. ,
Most mammalian mRNAs are conserved targets of microRNAs, Genome Res, vol.19, pp.92-105, 2009. ,
Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.18, pp.431-438, 2005. ,
The histone fold is a key structural motif of transcription factor TFIID, Trends Biochem. Sci, vol.26, pp.250-257, 2001. ,
URL : https://hal.archives-ouvertes.fr/hal-02126931
Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer, OncoTargets Ther, vol.10, pp.205-216, 2017. ,
Estrogen dependent signaling in reproductive tissues -a role for estrogen receptors and estrogen related receptors, Mol. Cell. Endocrinol, vol.348, pp.361-372, 2012. ,
To ERR in the estrogen pathway, Trends Endocrinol. Metab. TEM, vol.13, pp.220-225, 2002. ,
Transcriptional control of energy homeostasis by the estrogen-related receptors, Endocr. Rev, vol.29, pp.677-696, 2008. ,
Identification of a new class of steroid hormone receptors, Nature, vol.331, pp.91-94, 1988. ,
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell, vol.1, pp.555-567, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01431968
The cancer stem cell: The breast cancer driver. médecine/sciences 23, pp.1133-1142, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01431965
, , 2010.
, Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305, Breast Cancer Res. Treat, vol.119, pp.71-85
Estrogen-related receptor (ERR) protects against puromycin aminonucleoside-induced podocyte apoptosis by targeting PI3K/Akt signaling, Int. J. Biochem. Cell Biol, vol.78, pp.75-86, 2016. ,
G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motifdependent and -independent mechanisms, J. Biol. Chem, vol.292, pp.9932-9943, 2017. ,
, , 2013.
, Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line, Int. J. Cancer J. Int. Cancer, vol.133, pp.2769-2780
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years, N. Engl. J. Med, vol.375, pp.209-219, 2016. ,
Localization of DNase I hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promoters, J. Mol. Endocrinol, vol.10, pp.269-277, 1993. ,
Sequence and expression of human estrogen receptor complementary DNA, Science, vol.231, pp.1150-1154, 1986. ,
Production and Actions of Estrogens, N. Engl. J. Med, vol.346, pp.340-352, 2002. ,
, , 2005.
, Myoepithelial Cells: Their Origin and Function in Breast Morphogenesis and Neoplasia, J. Mammary Gland Biol. Neoplasia, vol.10, pp.261-272
A refined molecular taxonomy of breast cancer, Oncogene, vol.31, pp.1196-1206, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00611752
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway, Mol. Cell. Biol, vol.24, pp.8681-8690, 2004. ,
MicroRNA-136 functions as a tumor suppressor in osteosarcoma via regulating metadherin, Cancer Biomark. Sect. Dis. Markers, vol.22, pp.79-87, 2018. ,
A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-?36 expression and inhibits growth of ERnegative breast cancer MDA-MB-231 cells, Eur. J. Pharmacol, vol.714, pp.56-64, 2013. ,
,
, Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis, PLOS ONE, vol.12, 174843.
Human breast development, Semin. Cell Dev. Biol, vol.23, pp.567-573, 2012. ,
Diagram of the pathways of human steroidogenesis, WikiJournal Med, vol.1, p.5, 2014. ,
Estrogen receptor beta in breast cancer, Mol. Cell. Endocrinol, vol.382, pp.665-672, 2014. ,
Hallmarks of Cancer: The Next Generation, Cell, vol.144, pp.646-674, 2011. ,
Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen, Oncogene, vol.26, pp.7872-7884, 2007. ,
Menstrual Cycle: Basic Biology, Ann. N. Y. Acad. Sci, vol.1135, pp.10-18, 2008. ,
Organochlorine pesticides accumulation and breast cancer: A hospital-based case-control study, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol, 2017. ,
ERK/MAPK regulates ERR expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer, FEBS J, vol.281, pp.2431-2442, 2014. ,
A signature motif in transcriptional co-activators mediates binding to nuclear receptors, Nature, vol.387, pp.733-736, 1997. ,
, , 2007.
, Structural Insights into Corepressor Recognition by Antagonist-bound Estrogen Receptors, J. Biol. Chem, vol.282, pp.10449-10455
Controverse sur l'irradiation de la chaîne mammaire interne dans le cancer du sein, Cancer/radiothérapie, vol.18, pp.351-355, 2014. ,
Key stages of mammary gland development: Molecular mechanisms involved in the formation of the embryonic mammary gland, Breast Cancer Res, vol.7, pp.220-224, 2005. ,
Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters, Breast Cancer Res. BCR, vol.16, p.208, 2014. ,
Estetrol: a unique steroid in human pregnancy, J. Steroid Biochem. Mol. Biol, vol.110, pp.138-143, 2008. ,
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate, World J. Clin. Oncol, vol.7, pp.160-173, 2016. ,
Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3, J. Biol. Chem, vol.274, pp.22618-22626, 1999. ,
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, pp.3727-3734, 2008. ,
Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.10, pp.7490-7499, 2004. ,
Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand, J. Mol. Endocrinol, vol.31, pp.349-357, 2003. ,
G-Protein Coupled Estrogen Receptor in Breast Cancer, Int. J. Mol. Sci, vol.20, p.306, 2019. ,
Mechanisms for estrogen receptor expression in human cancer, Exp. Hematol. Oncol, vol.7, 2018. ,
Long noncoding RNA CRNDE activates Wnt/?catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer, Am. J. Transl. Res, vol.9, pp.1977-1989, 2017. ,
The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer, Int. J. Mol. Sci, vol.19, 2018. ,
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen, Nature, vol.456, pp.663-666, 2008. ,
Estradiol up-regulates AUF1p45 binding to stabilizing regions within the 3'-untranslated region of estrogen receptor alpha mRNA, J. Biol. Chem, vol.283, pp.1764-1772, 2008. ,
Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects, Biol. Reprod, vol.79, pp.711-717, 2008. ,
Mammary gland development: cell fate specification, stem cells and the microenvironment, Dev. Camb. Engl, vol.142, pp.1028-1042, 2015. ,
Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor, Cell, vol.79, pp.107-117, 1994. ,
Development of the Human Breast, Semin. Plast. Surg, vol.27, pp.5-12, 2013. ,
Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2017, 2017. ,
On the mechanism of estrogen action, Perspect. Biol. Med, vol.6, pp.47-59, 1962. ,
ESR1 mutations as a mechanism for acquired endocrine resistance in breast cancer, Nat. Rev. Clin. Oncol, vol.12, pp.573-583, 2015. ,
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations, Cancer Cell, vol.33, pp.173-186, 2018. ,
Estrogen receptor alpha and beta in health and disease, Best Pract. Res. Clin. Endocrinol. Metab, vol.29, pp.557-568, 2015. ,
Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues, J. Steroid Biochem. Mol. Biol, vol.112, pp.20-24, 2008. ,
Stimulation of estrogen receptor signaling by gamma synuclein, Cancer Res, vol.63, pp.3899-3903, 2003. ,
La cellule de Sertoli, une cellule endocrine. médecine/sciences 11, 1995. ,
The IG-DMR and the MEG3-DMR at Human Chromosome 14q32.2: Hierarchical Interaction and Distinct Functional Properties as Imprinting Control Centers, PLoS Genet, vol.6, 2010. ,
Transcription factor cross-talk: the estrogen receptor and NF-?B, Trends Endocrinol. Metab, vol.16, pp.46-52, 2005. ,
Transcription factor Ets1 cooperates with estrogen receptor ? to stimulate estradioldependent growth in breast cancer cells and tumors, PloS One, vol.8, p.68815, 2013. ,
Involvement of Estrogen Receptor Variant ER-?36, Not GPR30, Nongenomic Estrogen Signaling. Mol. Endocrinol, vol.24, pp.709-721, 2010. ,
A positive cross-regulation of HER2 and ER-?36 controls ALDH1 positive breast cancer cells, J. Steroid Biochem. Mol. Biol, vol.127, pp.262-268, 2011. ,
Opposite regulation of estrogen receptor-? and its variant ER-?36 by the Wilms' tumor suppressor WT1, Oncol. Lett, vol.2, pp.337-341, 2011. ,
Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer, Mol. Cell. Endocrinol, vol.483, pp.97-101, 2019. ,
, , 1991.
The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases, Front. Immunol, vol.6, 2016. ,
Estrogen and the skeleton, Trends Endocrinol. Metab. TEM, vol.23, pp.576-581, 2012. ,
Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells, J. Steroid Biochem. Mol. Biol, vol.74, pp.157-168, 2000. ,
ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases, Clin. Exp. Metastasis, vol.35, pp.707-712, 2018. ,
Synergism of closely adjacent estrogenresponsive elements increases their regulatory potential, J. Mol. Biol, vol.201, pp.537-544, 1988. ,
Estrogen receptor interaction with estrogen response elements, Nucleic Acids Res, vol.29, pp.2905-2919, 2001. ,
Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer, J. Natl. Cancer Inst, vol.101, pp.1725-1729, 2009. ,
Cellular reprogramming by the conjoint action of ER?, FOXA1, and GATA3 to a ligand-inducible growth state, Mol. Syst. Biol, vol.7, p.526, 2011. ,
Minireview: genomic organization of the human ERalpha gene promoter region, Mol. Endocrinol. Baltim. Md, vol.15, pp.2057-2063, 2001. ,
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland, Cell, vol.127, pp.1041-1055, 2006. ,
Estrogen receptors regulate innate immune cells and signaling pathways, Cell. Immunol, vol.294, pp.63-69, 2015. ,
Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells, Mol. Cell. Biol, vol.15, pp.6710-6719, 1995. ,
Cloning of a novel receptor expressed in rat prostate and ovary, Proc. Natl. Acad. Sci. U. S. A, vol.93, pp.5925-5930, 1996. ,
The structure of the nuclear hormone receptors, Steroids, vol.64, pp.310-319, 1999. ,
The Dynamic Structure of the Estrogen Receptor, J. Amino Acids, 2011. ,
2-Methoxyestradiol, a promising anticancer agent, Pharmacotherapy, vol.23, pp.165-172, 2003. ,
Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor, J. Mol. Endocrinol, vol.19, pp.207-226, 1997. ,
Micro-RNAs and breast cancer, Mol. Oncol, vol.4, pp.230-241, 2010. ,
Cracking the estrogen receptor's posttranslational code in breast tumors, Endocr. Rev, vol.32, pp.597-622, 2011. ,
Oncogenes and Tumor Suppressor Genes, Cold Spring Harb. Perspect. Biol, vol.2, 2010. ,
Transcription of eukaryotic protein-coding genes, Annu. Rev. Genet, vol.34, pp.77-137, 2000. ,
The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2, Oncotarget, 2017. ,
Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.4807-4812, 2003. ,
Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis, Pathol. Res. Pract, vol.214, pp.750-766, 2018. ,
Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis, Cancer Res, vol.79, pp.1054-1068, 2019. ,
,
, Differential Ligand Binding Affinities of Human Estrogen Receptor-? Isoforms, PLoS ONE, vol.8
, , 2010.
, Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a, PLoS ONE, vol.5
, , 2010.
, ER-?36, a Variant of ER-?, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways, PLoS ONE, vol.5
Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer, Oncogene, vol.29, pp.1114-1122, 2010. ,
The complex nature of oestrogen signalling in breast cancer: enemy or ally?, Biosci. Rep, vol.36, 2016. ,
Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma, Oncogene, vol.26, pp.2115-2125, 2007. ,
Identification of chemoresistance-associated miRNAs in breast cancer, Cancer Manag. Res, vol.10, pp.4747-4757, 2018. ,
Breast cancer: The translation of big genomic data to cancer precision medicine, Cancer Sci, vol.109, pp.497-506, 2018. ,
Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.17126-17131, 2004. ,
Crosstalk between Wnt/?-Catenin and NF-?B Signaling Pathway during, Inflammation. Front. Immunol, vol.7, 2016. ,
Mammary Gland Development, Wiley Interdiscip. Rev. Dev. Biol, vol.1, pp.533-557, 2012. ,
The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells, J. Biol. Chem, vol.281, pp.25167-25176, 2006. ,
Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR, Mol. Endocrinol. Baltim. Md, vol.30, pp.335-347, 2016. ,
PBX1 Genomic Pioneer Function Drives ER? Signaling Underlying Progression in Breast Cancer, PLOS Genet, vol.7, p.1002368, 2011. ,
Histological, molecular and functional subtypes of breast cancers, Cancer Biol. Ther, vol.10, pp.955-960, 2010. ,
Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland, J. Mammary Gland Biol. Neoplasia, vol.15, pp.301-318, 2010. ,
Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple, Endocr. Rev, vol.34, pp.1-32, 2013. ,
, , 2012.
Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients, PloS One, vol.8, 2013. ,
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24-stem cell-like breast cancer cells in human tumors, J. Clin. Invest, vol.121, pp.2723-2735, 2011. ,
Variations in pattern of pubertal changes in girls, Arch. Dis. Child, vol.44, pp.291-303, 1969. ,
Estrogen receptor and aryl hydrocarbon receptor signaling pathways, Nucl. Recept, 2006. ,
, , 2005.
Amphiregulin: role in mammary gland development and breast cancer, J. Mammary Gland Biol. Neoplasia, vol.13, pp.159-169, 2008. ,
The Nuclear Receptor Superfamily at Thirty, Methods Mol. Biol. Clifton NJ, vol.1443, pp.3-9, 2016. ,
AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs, Nucleic Acids Res, vol.27, pp.4040-4049, 1999. ,
Identification of ERF-1 as a member of the AP2 transcription factor family, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.4342-4347, 1997. ,
Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis, Cancer Res, vol.65, pp.11259-11264, 2005. ,
Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique, Genomics, vol.17, pp.263-265, 1993. ,
Genetically engineered mice as experimental tools to dissect the critical events in breast cancer, Adv. Cancer Res, vol.121, pp.331-382, 2014. ,
Post-transcriptional Mechanisms in Endocrine Regulation, 2015. ,
Les inhibiteurs de tyrosine kinase en oncologie -Tyrosine kinase inhibitors in oncology, vol.22, pp.51-62, 2008. ,
Perinatal programming of adult rat germ cell death after exposure to xenoestrogens: role of microRNA miR-29 family in the down-regulation of DNA methyltransferases and Mcl-1, Endocrinology, vol.153, pp.1936-1947, 2012. ,
A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes, Cell, vol.126, pp.1203-1217, 2006. ,
Estrogen-Related Receptors in Breast Cancer and Prostate Cancer, Front. Endocrinol, vol.6, p.83, 2015. ,
Progesterone receptor modulates ER? action in breast cancer, Nature, vol.523, pp.313-317, 2015. ,
,
, BCDB A database for breast cancer research and information. Bioinformation, vol.5, pp.1-3
Epigenetic regulation mechanisms of microRNA expression, Biomol. Concepts, vol.8, 2017. ,
Estrogen Receptor-Mediated Rapid Signaling, Endocrinology, vol.147, pp.5557-5563, 2006. ,
ER beta: identification and characterization of a novel human estrogen receptor, FEBS Lett, vol.392, pp.49-53, 1996. ,
The mammary myoepithelial cell, Int. J. Dev. Biol, vol.55, pp.763-771, 2011. ,
Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha, Endocrinology, vol.143, pp.2357-2365, 2002. ,
Perinatal Exposure to Bisphenol-A Alters Peripubertal Mammary Gland Development in Mice, Endocrinology, vol.146, pp.4138-4147, 2005. ,
Biological determinants of endocrine resistance in breast cancer, Nat. Rev. Cancer, vol.9, pp.631-643, 2009. ,
Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients, Int. J. Mol. Sci, vol.20, 2019. ,
Expression of basal and luminal cytokeratins in breast cancer and their correlation with clinicopathological prognostic variables, Indian J. Med. Sci, vol.63, p.152, 2009. ,
The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1), Cancer Treat. Res. Commun, vol.19, p.100123, 2019. ,
Cancer epigenetics: Moving forward, PLoS Genet, vol.14, p.1007362, 2018. ,
Hormonal regulation of the immune microenvironment in the mammary gland, J. Mammary Gland Biol. Neoplasia, vol.19, pp.229-239, 2014. ,
CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor, Mol. Endocrinol. Baltim. Md, vol.22, pp.263-272, 2008. ,
Hormonal Regulation of Mammary Differentiation and Milk Secretion, J. Mammary Gland Biol. Neoplasia, 2002. ,
Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease, Reprod. Camb. Engl, vol.135, pp.713-721, 2008. ,
, , 1999.
Structure/function relationships underlying regulation of FOXO transcription factors, Oncogene, vol.27, pp.2263-2275, 2008. ,
, , 1998.
, Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human, Nucleic Acids Res, vol.26, pp.3505-3512
Genomic Targets of Nuclear Estrogen Receptors, Mol. Endocrinol, vol.18, pp.1859-1875, 2004. ,
The molecular mechanisms underlying the ER?-36-mediated signaling in breast cancer, Oncogene, vol.36, pp.2503-2514, 2017. ,
, , 2015.
Circular RNAs Act as miRNA Sponges, Adv. Exp. Med. Biol, vol.1087, pp.67-79, 2018. ,
miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA, Mol. Cell. Biol, vol.29, pp.3783-3790, 2009. ,
, , 2015.
, Mol. Biosyst, vol.11, pp.2998-3010
miRmine: a database of human miRNA expression profiles, Bioinforma. Oxf. Engl, vol.33, pp.1554-1560, 2017. ,
Human cancer databases (Review), 2015. ,
, Oncol. Rep, vol.33, pp.3-18
Expression of HER2 and its association with AP-2 in breast cancer, Eur. J. Cancer, vol.40, pp.1485-1495, 2004. ,
, , 2004.
, Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells, J. Steroid Biochem. Mol. Biol, vol.91, pp.1-9
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer, Cancer Res, vol.69, pp.6131-6140, 2009. ,
Endometrial cell calcium and oestrogen action, Nature, vol.253, p.357, 1975. ,
Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.24, pp.2452-2463, 2018. ,
Genomic organization of the human oestrogen receptor gene, EMBO J, vol.7, pp.3385-3388, 1988. ,
Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer, Int. J. Mol. Sci, vol.20, 2019. ,
The Aryl Hydrocarbon Receptor: A Target for Breast Cancer Therapy, J. Cancer Ther, vol.4, pp.1177-1186, 2013. ,
Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery, Exp. Biol. Med. Maywood NJ, vol.228, pp.111-133, 2003. ,
Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR, Breast Cancer Res. Treat, vol.111, pp.15-25, 2008. ,
The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs), Mol. Cell. Endocrinol, vol.376, pp.23-32, 2013. ,
GPER Mediates Non-Genomic Effects of Estrogen, Methods Mol. Biol. Clifton NJ, vol.1366, pp.471-488, 2016. ,
A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells, Oncotarget, vol.8, pp.46728-46744, 2017. ,
, , 2013.
, Small-Molecule Hormones: Molecular Mechanisms of Action, Int. J. Endocrinol, 2013.
Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors, J. Immunol. Res, 2016. ,
Advances in the understanding of the structure and function of ER-?36,a novel variant of human estrogen receptor-alpha, J. Steroid Biochem. Mol. Biol, vol.127, pp.231-237, 2011. ,
BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer, Mol. Cell. Biol, vol.24, pp.5900-5913, 2004. ,
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers, J. Natl. Cancer Inst, vol.101, pp.80-87, 2009. ,
Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling, Mol. Cell, vol.11, pp.695-707, 2003. ,
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling, vol.307, p.6, 2005. ,
Molecular profiling of patient-derived breast cancer xenografts, Breast Cancer Res, vol.14, p.11, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00675301
Amino acids and mammary gland development: nutritional implications for milk production and neonatal growth, J. Anim. Sci. Biotechnol, vol.7, 2016. ,
Hormonal impact on tumor growth and progression, Exp. Oncol, vol.37, pp.162-172, 2015. ,
Cooperation of signalling pathways in embryonic mammary gland development, Nat. Rev. Genet, vol.8, pp.963-972, 2007. ,
Activating ESR1 mutations in hormone-resistant metastatic breast cancer, Nat. Genet, vol.45, pp.1446-1451, 2013. ,
Aromatase deficiency in men: a clinical perspective, Nat. Rev. Endocrinol, vol.5, pp.559-568, 2009. ,
Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms, Environ. Res, vol.160, pp.152-182, 2018. ,
Oestrogen receptor facilitates the formation of preinitiation complex assembly: involvement of the general transcription factor TFIIB, Biochem. J, vol.336, pp.639-646, 1998. ,
Nonclassical genomic ER/Sp and ER/AP-1 signaling pathways, J. Mol. Endocrinol, vol.41, pp.263-275, 2008. ,
Mammary stroma in development and carcinogenesis, J. Mammary Gland Biol. Neoplasia, vol.18, pp.189-197, 2013. ,
Estrogen metabolism and breast cancer, Cancer Lett, vol.356, pp.231-243, 2015. ,
Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders, Hum. Pathol, vol.25, pp.530-535, 1994. ,
Signal transducer and activator of transcription-3 and breast cancer prognosis, Am. J. Cancer Res, vol.1, pp.347-355, 2011. ,
The coactivator LXXLL nuclear receptor recognition motif, J. Pept. Res, vol.63, pp.207-212, 2004. ,
, High Level of Plasma Estradiol as a New Predictor of Ischemic Arterial Disease in Older Postmenopausal Women: The Three City Cohort Study, 2012.
, J. Am. Heart Assoc, vol.1
Endocrine Disrupting Chemicals and Disease Susceptibility, J. Steroid Biochem. Mol. Biol, vol.127, pp.204-215, 2011. ,
The role of estradiol in male reproductive function, Asian J. Androl, vol.18, pp.435-440, 2016. ,
Genomic structure of the promoters of the human estrogen receptor-alpha gene demonstrate changes in chromatin structure induced by AP2gamma, J. Biol. Chem, vol.276, pp.15519-15526, 2001. ,
A Review of the Carcinogenic Potential of Bisphenol A, Reprod. Toxicol. Elmsford N, vol.59, pp.167-182, 2016. ,
Correlations between the chemical structure and the pharmacological actions of the steroids, Endocrinology, vol.30, pp.437-453, 1942. ,
Celebrating 25 Years of MicroRNA Research: From Discovery to Clinical Application, Int. J. Mol. Sci, vol.20, 1987. ,
Various types and management of breast cancer: an overview, J. Adv. Pharm. Technol. Res, vol.1, pp.109-126, 2010. ,
The stimulation of HSD17B7 expression by estradiol provides a powerful feedforward mechanism for estradiol biosynthesis in breast cancer cells, Mol. Endocrinol. Baltim. Md, vol.25, pp.754-766, 2011. ,
Expression of ER-?36, a Novel Variant of Estrogen Receptor ?, and Resistance to Tamoxifen Treatment in Breast Cancer, J. Clin. Oncol, vol.27, pp.3423-3429, 2009. ,
, , 2010.
, Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha, Am. J. Pathol, vol.177, pp.964-973
Signaling pathways and steroid receptors modulating estrogen receptor ? function in breast cancer, Genes Dev, vol.32, pp.1141-1154, 2018. ,
ER?36--Another piece of the estrogen puzzle, Eur. J. Cell Biol, vol.94, pp.611-625, 2015. ,
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine, Int. J. Cancer, vol.123, pp.8-13, 2008. ,
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors, Mol. Cancer Res. MCR, vol.1, pp.981-991, 2003. ,
Expression of ER-?36, a novel variant of estrogen receptor in endometrial carcinoma and its clinical significance, Gynecol. Obstet. Invest, vol.75, pp.68-72, 2013. ,
Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen, Proc. Natl. Acad. Sci. U. S. A, vol.58, pp.2735-2742, 1967. ,
Regulation of estrogen receptor alpha gene mediated by promoter B responsible for its enhanced expressionin human breast cancer, Nucleic Acids Res, vol.27, pp.903-909, 1999. ,
What Signals Operate in the Mammary Niche?, Breast Dis, vol.29, pp.69-82, 2008. ,
One hundred years of hormones, EMBO Rep, vol.6, pp.490-496, 2005. ,
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation, Nature, vol.455, pp.1124-1128, 2008. ,
ER-?36 Interactions With Cytosolic Molecular Network in Acquired Tamoxifen Resistance, Clin. Breast Cancer, vol.17, pp.403-407, 2017. ,
Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption, J. Steroid Biochem. Mol. Biol, vol.102, pp.175-179, 2006. ,
Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells, Endocrinology, vol.146, pp.624-632, 2005. ,
Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.5671-5676, 2001. ,
Endocrine disruptor regulation of microRNA expression in breast carcinoma cells, PloS One, vol.7, 2012. ,
Estradiol regulates Tumor Necrosis Factor-? expression and secretion in Estrogen Receptor positive breast cancer cells, Mol. Cell. Endocrinol, vol.394, pp.21-28, 2014. ,
4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors beta and gamma, Endocrinology, vol.142, pp.4572-4575, 2001. ,
Single CpG site methylation controls estrogen receptor gene transcription and correlates with hormone therapy resistance, J. Steroid Biochem. Mol. Biol, vol.171, pp.209-217, 2017. ,
Tumor Heterogeneity in Breast Cancer, 2017. ,
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways, Cancer Res, vol.58, pp.5466-5472, 1998. ,
High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism, PLoS ONE, vol.13, 2018. ,
The crossroads of breast cancer progression: insights into the modulation of major signaling pathways, Onco Targets Ther, vol.10, pp.5491-5524, 2017. ,
Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation, Differ. Res. Biol. Divers, vol.71, pp.1-17, 2003. ,
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis, 2009. ,
, Genes Dev, vol.23, pp.2563-2577
Mammary stem cells and the differentiation hierarchy: current status and perspectives, Genes Dev, vol.28, pp.1143-1158, 2014. ,
, , 2012.
, GPER mediates the Egr-1 expression induced by 17?-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells, Breast Cancer Res. Treat, vol.133, pp.1025-1035
Estrogen receptor mRNA directed therapy for triple negative breast cancer, 2014. ,
The many faces of estrogen signaling, Biochem. Medica, vol.24, pp.329-342, 2014. ,
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice, Mol. Cell. Biol, vol.24, pp.5510-5520, 2004. ,
Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition, J. Biol. Chem, vol.278, pp.52093-52101, 2003. ,
Activation of the signal transducer and activator of transcription 3 pathway up-regulates estrogen receptor-beta expression in lung adenocarcinoma cells, Mol. Endocrinol. Baltim. Md, vol.25, pp.1145-1158, 2011. ,
Expression of ER?36 in gastric cancer samples and their matched normal tissues, Oncol. Lett, vol.3, pp.172-175, 2012. ,
, , 2016.
, Cyanidin-3-o-glucoside directly binds to ER?36 and inhibits EGFR-positive triple-negative breast cancer, Oncotarget, vol.7, pp.68864-68882
, , 2015.
, High ER?36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma: Medicine (Baltimore) 94, e1048
,
Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways, Biochem. Biophys. Res. Commun, vol.503, pp.1605-1609, 2018. ,
RelB NF-?B Represses Estrogen Receptor ? Expression via Induction of the Zinc Finger Protein Blimp1, Mol. Cell. Biol, vol.29, pp.3832-3844, 2009. ,
Estrogen receptor-?36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells, J. Steroid Biochem, 2017. ,
, Mol. Biol, vol.171, pp.318-327
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66, Biochem. Biophys. Res. Commun, vol.336, pp.1023-1027, 2005. ,
A variant of estrogen receptor-?, hER-?36: Transduction of estrogen-and antiestrogen-dependent membrane-initiated mitogenic signaling, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.9063-9068, 2006. ,
Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ, Breast Cancer Res. BCR, vol.8, p.203, 2006. ,
The Stat family of transcription factors have diverse roles in mammary gland development, Semin. Cell Dev. Biol, vol.19, pp.401-406, 2008. ,
The Estrogen Receptor Enhances AP-1 Activity by Two Distinct Mechanisms with Different Requirements for Receptor Transactivation Functions, Mol. Endocrinol, vol.13, pp.1672-1685, 1999. ,
Tumor heterogeneity 2016, Cancer Res, vol.76, pp.4-6, 2016. ,
Estrogen and vascular function, Vascul. Pharmacol, vol.38, pp.73-80, 2002. ,
Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis, J. Cell Biol, vol.162, pp.1123-1133, 2003. ,
Estrogen receptor ?36 mediates a bone-sparing effect of 17?-estrodiol in postmenopausal women, J. Bone Miner. Res, vol.26, pp.156-168, 2011. ,
Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis, Pathol. Res. Pract, vol.214, pp.644-654, 2018. ,
Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer, Breast Cancer Res. BCR, vol.7, pp.753-764, 2005. ,
miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer, Oncol. Rep, vol.36, pp.65-71, 2016. ,
ER?36, a variant of estrogen receptor ?, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells, PLoS ONE, vol.12, 2017. ,
, , 2016.
Mammary gland stem cells and their application in breast cancer, Oncotarget, vol.8, pp.10675-10691, 2016. ,
Molecular mechanism of estrogenestrogen receptor signaling, Reprod. Med. Biol, vol.16, pp.4-20, 2017. ,
Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells, vol.14, 1996. ,
The effects of estrogen-responsive element-and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta, Mol. Endocrinol. Baltim. Md, vol.16, pp.674-693, 2002. ,
Disruption of the ER-?36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells, PloS One, vol.9, 2014. ,
Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology, J. Biol. Chem, vol.285, pp.38743-38750, 2010. ,
Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors, Carcinogenesis, vol.21, pp.2193-2201, 2000. ,
Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice, Dev. Growth Differ, vol.41, pp.675-684, 1999. ,
Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase, Mol. Cell. Biol, vol.20, pp.2592-2603, 2000. ,
Mammary Development and Breast Cancer: A Wnt Perspective, Cancers, vol.8, 2016. ,
MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1, Mol. Med. Rep, vol.12, pp.4647-4651, 2015. ,
Prediction of potential disease-associated microRNAs using structural perturbation method, Bioinforma. Oxf. Engl, vol.34, pp.2425-2432, 2018. ,
STAT3 in Cancer-Friend or Foe? Cancers, vol.6, pp.1408-1440, 2014. ,
,
, Myocardin-related transcription factor A is up-regulated by 17?-estradiol and promotes migration of MCF-7 breast cancer cells via transactivation of MYL9 and CYR61, Acta Biochim. Biophys. Sin, vol.45, pp.921-927
Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis, Dev. Biol, vol.256, pp.127-145, 2003. ,
, , 2012.
, Estrogen-independent effects of ER-?36 in ER-negative breast cancer, Steroids, vol.77, pp.666-673
ZEB1 induces ER-? promoter hypermethylation and confers antiestrogen resistance in breast cancer, Cell Death Dis, vol.8, p.2732, 2017. ,
Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context, Environ. Health Perspect, vol.111, pp.1877-1882, 2003. ,
The elevated level of ER?36 is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma, Steroids, vol.87, pp.39-45, 2014. ,
Akt, FoxO and regulation of apoptosis, Biochim. Biophys. Acta, vol.1813, pp.1978-1986, 2011. ,
A Positive Feedback Loop of ER-?36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells, Oncogene, vol.30, pp.770-780, 2011. ,
miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1, Biol. Res, vol.50, p.27, 2017. ,
Involvement of ER-?36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells, Oncol. Rep, vol.27, pp.2057-2065, 2012. ,
Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis, Cancer, vol.98, pp.18-23, 2003. ,
Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells, Cancer Res, vol.67, pp.3955-3962, 2007. ,
Estrogen receptor beta: an overview and update, Nucl. Recept. Signal, vol.6, p.3, 2008. ,
Quantitative profiles of the mRNAs of ER-? and its novel variant ER-?36 in breast cancers and matched normal tissues*, J. Zhejiang Univ. Sci. B, vol.11, pp.144-150, 2010. ,
Identification of a novel human estrogen receptor-? splice variant able to enhance malignant biological behaviors of breast cancer cells, Oncol. Lett, vol.15, pp.5339-5344, 2018. ,
ER-?36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway, J. Exp. Clin. Cancer Res. CR, vol.37, p.123, 2018. ,
MicroRNA 136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen activated protein kinase kinase 4, Mol. Med. Rep, vol.17, pp.4803-4810, 2018. ,
Get to Know Your Sex Hormones, 2019. ,
Estrogen receptor-alpha (ER-?) suppresses expression of its variant ER-?36, FEBS Lett, vol.583, pp.1368-1374, 2009. ,
PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1, EMBO J, vol.26, pp.3534-3544, 2007. ,